• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经丝轻链蛋白在神经退行性痴呆中的研究:系统评价和网络荟萃分析。

Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.

机构信息

Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, China.

Department of Cardiology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, China.

出版信息

Neurosci Biobehav Rev. 2019 Jul;102:123-138. doi: 10.1016/j.neubiorev.2019.04.014. Epub 2019 Apr 24.

DOI:10.1016/j.neubiorev.2019.04.014
PMID:31026486
Abstract

The diagnostic value of neurofilament light chain protein in neurodegenerative dementia diseases is still controversial. A systematic literature search was performed to identify relevant case-control studies conducted through October 2018. Traditional and net meta-analyses were performed based on 42 studies that tested the diagnostic performance of neurofilament light chain protein (NfL) concentration in CSF and serum/plasma from patients with neurodegenerative dementia. CSF and serum/plasma NfL levels were significantly increased in patients with neurodegenerative dementia diseases. Network meta-analysis showed a significant reduction in CSF NfL levels during mild cognitive impairment, whereas an increase was observed in vascular dementia compared to Alzheimer's disease. Surface under the cumulative ranking curve and cluster analysis showed that the NfL concentration in CSF (vascular dementia, frontotemporal dementia, and Alzheimer's disease) and serum/plasma (frontotemporal dementia and Alzheimer's disease) ranked first among neurodegenerative dementia diseases. NfL is an important biomarker that can help clinical neurologists make early diagnoses of neurodegenerative diseases, so patients can receive prompt treatment.

摘要

神经丝轻链蛋白在神经退行性痴呆疾病中的诊断价值仍存在争议。本研究通过系统文献检索,确定了截至 2018 年 10 月进行的相关病例对照研究。对检测神经丝轻链蛋白(NfL)浓度在脑脊液和血清/血浆中对神经退行性痴呆患者的诊断性能的 42 项研究进行了传统和净荟萃分析。神经退行性痴呆患者的脑脊液和血清/血浆 NfL 水平显著升高。网络荟萃分析显示,轻度认知障碍患者的脑脊液 NfL 水平显著降低,而血管性痴呆患者的 NfL 水平与阿尔茨海默病相比则升高。累积排序曲线下面积和聚类分析表明,脑脊液中 NfL 浓度(血管性痴呆、额颞叶痴呆和阿尔茨海默病)和血清/血浆中 NfL 浓度(额颞叶痴呆和阿尔茨海默病)在神经退行性痴呆疾病中排名第一。NfL 是一种重要的生物标志物,可以帮助临床神经科医生对神经退行性疾病进行早期诊断,从而使患者能够得到及时治疗。

相似文献

1
Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.神经丝轻链蛋白在神经退行性痴呆中的研究:系统评价和网络荟萃分析。
Neurosci Biobehav Rev. 2019 Jul;102:123-138. doi: 10.1016/j.neubiorev.2019.04.014. Epub 2019 Apr 24.
2
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.脑脊髓液神经丝轻链蛋白水平与痴呆、运动神经元病和运动障碍患者认知的相关性。
JAMA Neurol. 2019 Mar 1;76(3):318-325. doi: 10.1001/jamaneurol.2018.3746.
3
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.神经丝轻链、神经胶质纤维酸性蛋白和神经元五聚素-2 的联合检测可区分额颞叶痴呆和其他类型痴呆。
J Alzheimers Dis. 2022;90(1):363-380. doi: 10.3233/JAD-220318.
4
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.快速进展性神经退行性痴呆症中的 CSF 神经丝轻链特征。
Alzheimers Res Ther. 2018 Jan 11;10(1):3. doi: 10.1186/s13195-017-0331-1.
5
Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study.记忆门诊实践中的血浆神经丝轻链:来自一项真实研究的证据。
Neurobiol Dis. 2023 Jan;176:105937. doi: 10.1016/j.nbd.2022.105937. Epub 2022 Dec 1.
6
Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.在专科护理环境中诊断为任何类型痴呆的患者中,用于阿尔茨海默病性痴呆鉴别诊断的血浆和脑脊液 ABeta42。
Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD010945. doi: 10.1002/14651858.CD010945.pub2.
7
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.使用血浆生物标志物对神经退行性痴呆进行 AT(N)分类。
J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1206-1214. doi: 10.1136/jnnp-2021-326603. Epub 2021 Jun 8.
8
Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer's disease and other neurodegenerative dementias in a large Chinese cohort.在中国一个大型队列中评估六种血浆生物标志物对阿尔茨海默病和其他神经退行性痴呆的诊断性能。
Alzheimers Res Ther. 2025 Apr 3;17(1):71. doi: 10.1186/s13195-025-01712-y.
9
Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.神经退行性痴呆症患者脑脊液神经丝轻链水平:在朊病毒病鉴别诊断中评估诊断准确性。
Alzheimers Dement. 2018 Jun;14(6):751-763. doi: 10.1016/j.jalz.2017.12.008. Epub 2018 Feb 3.
10
Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.额颞叶痴呆谱系患者的脑脊液生物标志物:一项单中心研究。
J Alzheimers Dis. 2018;66(2):551-563. doi: 10.3233/JAD-180409.

引用本文的文献

1
Blood Biomarkers of Neurodegeneration over Four Decades After Toxic Oil Syndrome: A Case-Control Study.中毒性油综合征后四十年神经退行性变的血液生物标志物:一项病例对照研究
Int J Mol Sci. 2025 May 27;26(11):5122. doi: 10.3390/ijms26115122.
2
Toward More Holistic Early Traumatic Brain Injury Evaluation and Care: Recommendations from the 2024 National Institute of Neurological Disorders and Stroke Traumatic Brain Injury Classification and Nomenclature Initiative Psychosocial and Environmental Modifiers Working Group.迈向更全面的早期创伤性脑损伤评估与护理:2024年美国国立神经疾病和中风研究所创伤性脑损伤分类与命名倡议心理社会和环境修饰因素工作组的建议
J Neurotrauma. 2025 Jul;42(13-14):1023-1037. doi: 10.1089/neu.2024.0569. Epub 2025 Jun 4.
3
Emerging nano-derived therapy for the treatment of dementia: a comprehensive review.新兴的纳米衍生疗法治疗痴呆症:综述
Drug Deliv Transl Res. 2025 Apr 23. doi: 10.1007/s13346-025-01863-3.
4
The relationship between triglyceride-glucose index and serum neurofilament light chain: Findings from NHANES 2013-2014.甘油三酯-葡萄糖指数与血清神经丝轻链之间的关系:2013 - 2014年美国国家健康与营养检查调查结果
PLoS One. 2025 Apr 10;20(4):e0321226. doi: 10.1371/journal.pone.0321226. eCollection 2025.
5
Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis.帕金森病和非典型帕金森综合征中的脑脊液和血液神经丝轻链:系统评价和贝叶斯网络荟萃分析
J Neurol. 2025 Apr 3;272(4):311. doi: 10.1007/s00415-025-13051-x.
6
Blood biomarkers for vascular cognitive impairment based on neuronal function: a systematic review and meta-analysis.基于神经元功能的血管性认知障碍血液生物标志物:系统评价与荟萃分析
Front Neurol. 2025 Feb 7;16:1496711. doi: 10.3389/fneur.2025.1496711. eCollection 2025.
7
Plasma homocysteine level and trajectories in association with longitudinal increase in plasma neurofilament light among urban adults.城市成年人血浆同型半胱氨酸水平及轨迹与血浆神经丝轻链纵向增加的关系
Geroscience. 2025 Feb 19. doi: 10.1007/s11357-025-01567-z.
8
Alzheimer's Disease polygenic risk, the plasma proteome, and dementia incidence among UK older adults.英国老年人中的阿尔茨海默病多基因风险、血浆蛋白质组与痴呆症发病率
Geroscience. 2025 Apr;47(2):2507-2523. doi: 10.1007/s11357-024-01413-8. Epub 2024 Nov 26.
9
The early diagnosis of Alzheimer's disease: Blood-based panel biomarker discovery by proteomics and metabolomics.阿尔茨海默病的早期诊断:基于蛋白质组学和代谢组学的基于血液的面板生物标志物发现。
CNS Neurosci Ther. 2024 Nov;30(11):e70060. doi: 10.1111/cns.70060.
10
Sex differences in the association between repetitive negative thinking and neurofilament light.反复消极思维与神经丝轻链之间关联中的性别差异。
Npj Ment Health Res. 2024 Nov 11;3(1):53. doi: 10.1038/s44184-024-00093-8.